585.48
price down icon2.42%   -14.52
after-market After Hours: 586.79 1.31 +0.22%
loading

Regeneron Pharmaceuticals Inc Stock (REGN) Forecast

The Regeneron Pharmaceuticals Inc (REGN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1,460.76, representing a +149.50% increase from the current price of $585.48. The highest analyst price target is $1,491.38, and the lowest is $1,430.14.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month REGN Price Target
Average 1,316.18 (+124.80% Upside)
loading

Is Regeneron Pharmaceuticals Inc (REGN) A Buy Now?

Oscillators
Name Value Action
RSI(14) 53.18 Neutral
STOCH(9,6) 54.22 Neutral
STOCHRSI(14) 51.11 Neutral
MACD(12,26) 4.7453 Buy
ADX(14) 17.60 Neutral
William %R -47.28 Neutral
CCI(14) 40.51 Neutral
Buy: 1 Sell: 0 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
577.27
Buy
583.53
Buy
MA20
576.64
Buy
579.29
Buy
MA50
572.21
Buy
572.75
Buy
MA100
558.42
Buy
579.85
Buy
MA200
607.92
Sell
651.72
Sell
Buy: 8 Sell: 2 Neutral: 0
Summary: Buy
According to our latest analysis, REGN could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 2 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on REGN, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 53.18 indicates that REGN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 54.22 indicates that REGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 51.11 indicates that REGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 17.6 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 40.51 indicates that REGN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term REGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Regeneron Pharmaceuticals Inc financial reports and earnings history, Regeneron Pharmaceuticals Inc (REGN) stock could reach $1,537.19 by 2030, $5,259.22 by 2040 and $6,823.21 by 2050. See the projected annual prices until 2050 of the Regeneron Pharmaceuticals Inc stock below:

  • Regeneron Pharmaceuticals Inc (REGN) is expected to reach an average price of $4,016.37 in 2035, with a high prediction of $4,043.03 and a low estimate of $3,960.32. This indicates an $586.00% rise from the last recorded price of $585.48.
  • Regeneron Pharmaceuticals Inc (REGN) stock is projected to chart a bullish course in 2040, with an average price target of $5,238.86, representing an $794.80% surge from its current level. The forecast ranges from a conservative $5,208.21 to a sky-high $5,259.22.
  • Our analysts predict Regeneron Pharmaceuticals Inc (REGN) to jump 947.64% by 2045, soaring from $6,052.28 to an average price of $6,133.71, potentially reaching $6,160.34. While $6,052.28 is the low estimate, the potential upside is significant.
  • Regeneron Pharmaceuticals Inc (REGN) stock is expected to climb by 2050, reaching an average of $6,819.16, a $1,065% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6,823.21 and $6,683.61, respectively, highlighting the market's uncertainty.

Regeneron Pharmaceuticals Inc Stock (REGN) Year by Year Forecast

Regeneron Pharmaceuticals Inc Stock (REGN) Price Forecast for 2025

Regeneron Pharmaceuticals Inc Stock (REGN) is expected to reach an average price of $1,304.14 in 2025, with a high prediction of $1,529.39 and a low estimate of $1,078.89. This indicates an +122.75% rise from the last recorded price of $585.48.
Month Average Low High Change from today's price
November, 2025 $1,461.39 $1,430.14 $1,491.38 +149.61%
December, 2025 $1,464.29 $1,453.96 $1,529.39 +150.10%

Regeneron Pharmaceuticals Inc Stock (REGN) Price Forecast for 2026

The predicted value for Regeneron Pharmaceuticals Inc (REGN) in 2026 is set at an average of $1,361.55. Estimates vary from a peak of $1,790.90 to a trough of $932.20, indicating an +132.55% surge from the present price of $585.48.
Month Average Low High Change from today's price
January, 2026 $1,450.08 $932.20 $1,521.36 +147.67%
February, 2026 $1,449.62 $1,419.08 $1,468.96 +147.60%
March, 2026 $1,484.55 $1,429.75 $1,491.50 +153.56%
April, 2026 $1,456.11 $1,456.01 $1,533.18 +148.70%
May, 2026 $1,474.73 $1,434.39 $1,498.74 +151.88%
June, 2026 $1,491.50 $1,456.46 $1,505.32 +154.75%
July, 2026 $1,552.07 $1,489.95 $1,556.58 +165.09%
August, 2026 $1,576.29 $1,535.23 $1,584.00 +169.23%
September, 2026 $1,650.26 $1,571.32 $1,660.81 +181.87%
October, 2026 $1,696.26 $1,644.30 $1,700.16 +189.72%
November, 2026 $1,773.86 $1,692.39 $1,782.19 +202.97%
December, 2026 $1,724.76 $1,723.37 $1,790.90 +194.59%

Regeneron Pharmaceuticals Inc Stock (REGN) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Regeneron Pharmaceuticals Inc (REGN) is $1,829.92, with a high forecast of $1,989.36 and a low forecast of $1,670.47. This indicates an +212.55% increase from the last price of $585.48.
Month Average Low High Change from today's price
January, 2027 $1,707.25 $1,670.47 $1,707.88 +191.60%
February, 2027 $1,802.85 $1,708.22 $1,812.01 +207.93%
March, 2027 $1,788.57 $1,784.13 $1,843.15 +205.49%
April, 2027 $1,799.82 $1,771.35 $1,828.21 +207.41%
May, 2027 $1,822.84 $1,786.54 $1,834.88 +211.34%
June, 2027 $1,839.41 $1,809.41 $1,848.70 +214.17%
July, 2027 $1,932.71 $1,831.83 $1,944.50 +230.11%
August, 2027 $1,937.67 $1,923.40 $1,989.36 +230.95%
September, 2027 $1,961.51 $1,858.82 $1,968.33 +235.03%
October, 2027 $1,864.95 $1,822.01 $1,965.33 +218.53%
November, 2027 $1,920.87 $1,868.55 $1,923.78 +228.08%
December, 2027 $1,947.13 $1,874.59 $1,964.37 +232.57%

Regeneron Pharmaceuticals Inc Stock (REGN) Price Forecast for 2028

In 2028, Regeneron Pharmaceuticals Inc (REGN) is projected to reach an average price of $2,109.23, with a high projection of $2,308.82 and a low estimate of $1,909.64. This indicates an +260.26% rise from the last price of $585.48.
Month Average Low High Change from today's price
January, 2028 $1,914.33 $1,909.64 $1,974.76 +226.97%
February, 2028 $2,037.88 $1,909.76 $2,092.21 +248.07%
March, 2028 $2,116.88 $2,047.47 $2,128.94 +261.56%
April, 2028 $2,119.66 $2,074.02 $2,145.41 +262.04%
May, 2028 $2,129.29 $2,114.25 $2,173.90 +263.68%
June, 2028 $2,139.84 $2,082.02 $2,157.89 +265.48%
July, 2028 $2,190.75 $2,140.00 $2,233.62 +274.18%
August, 2028 $2,199.26 $2,170.29 $2,237.53 +275.63%
September, 2028 $2,296.28 $2,181.74 $2,305.10 +292.20%
October, 2028 $2,244.95 $2,227.74 $2,308.82 +283.44%
November, 2028 $2,241.92 $2,213.32 $2,262.44 +282.92%
December, 2028 $2,235.80 $2,202.07 $2,303.61 +281.88%

Regeneron Pharmaceuticals Inc Stock (REGN) Price Forecast for 2029

The 2029 price forecast for Regeneron Pharmaceuticals Inc Stock (REGN) is $2,081.82 on average, with a high prediction of $2,668.54 and a low estimate of $1,495.10. This represents an +255.58% increase from the previous price of $585.48.
Month Average Low High Change from today's price
January, 2029 $2,278.29 $2,213.12 $2,284.35 +289.13%
February, 2029 $2,382.03 $2,266.32 $2,399.18 +306.85%
March, 2029 $2,390.37 $2,371.28 $2,405.03 +308.28%
April, 2029 $2,421.90 $2,378.22 $2,436.24 +313.66%
May, 2029 $2,400.33 $2,359.11 $2,441.64 +309.98%
June, 2029 $2,431.54 $2,390.17 $2,445.10 +315.31%
July, 2029 $2,510.27 $2,423.06 $2,531.84 +328.75%
August, 2029 $2,593.88 $2,507.19 $2,616.76 +343.03%
September, 2029 $2,647.60 $2,581.78 $2,652.04 +352.21%
October, 2029 $2,652.75 $2,631.16 $2,668.54 +353.09%
November, 2029 $2,597.63 $2,591.24 $2,666.09 +343.68%
December, 2029 $1,495.36 $1,495.10 $2,625.49 +155.41%

Regeneron Pharmaceuticals Inc Stock (REGN) Price Forecast for 2030

Regeneron Pharmaceuticals Inc Stock (REGN) is expected to reach an average price of $1,787.12 in 2030, with a high forecast of $2,084.62 and a low forecast of $1,489.63. This signifies an +205.24% surge from the last price of $585.48.
Month Average Low High Change from today's price
January, 2030 $1,528.93 $1,489.63 $1,537.19 +161.14%
February, 2030 $1,544.47 $1,532.34 $1,565.69 +163.80%
March, 2030 $1,588.26 $1,552.79 $1,597.10 +171.28%
April, 2030 $1,602.73 $1,584.22 $1,606.91 +173.75%
May, 2030 $1,629.65 $1,600.63 $1,643.10 +178.34%
June, 2030 $1,689.14 $1,632.44 $1,690.60 +188.50%
July, 2030 $1,781.14 $1,693.46 $1,786.57 +204.22%
August, 2030 $1,826.97 $1,786.96 $1,828.64 +212.05%
September, 2030 $1,862.73 $1,830.07 $1,868.55 +218.15%
October, 2030 $1,920.48 $1,833.08 $1,928.25 +228.02%
November, 2030 $2,004.00 $1,920.76 $2,043.20 +242.28%
December, 2030 $2,069.33 $1,990.15 $2,084.62 +253.44%
$452.00
price down icon 0.95%
$787.94
price down icon 1.51%
biotechnology ONC
$344.53
price up icon 0.19%
$158.28
price up icon 0.71%
$105.16
price down icon 0.31%
Cap:     |  Volume (24h):